drugset / Trial / NCT01806792
Post-menopausal Women Osteoporosis(Phase III)
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and the safety of Risedronate, cholecalciferol combination tablet in patients with Osteoporosis
Timeline
- Start
- 2009-11
- Primary completion
- 2010-08
- Completion
- 2011-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cholecalciferol | Other / unclassified | 30000 iu | — |
| Comparator | Risedronate | Small molecule | 150 mg | — |